TOMI Environmental Solutions has announced the successful deployment of SteraBot, a pilot disinfection robot, at the Lithuanian University Hospital of Health Sciences.
In an effort to meet new standards in automation and robotics to help halt the spread of COVID-19 as well as other existing and emerging pathogens, TOMI has developed SteraBot, a significant advancement in SteraMist disinfection technology.
This first generation of SteraMist robotics technology is the result of collaboration with RV Automation Technology of Hong Kong.
By utilising extensively tested, implemented, and patented ionised Hydrogen Peroxide technology, SteraBot is expected to protect hospital staff, patients, and visitors. Additionally, full-time equivalent costs and personal protection equipment usage are expected to be greatly reduced.
The SteraBot incorporates cutting-edge Automated Guided Vehicle (AGV) technology for intuitive maneuverability in unmapped environments. The software allows for enhanced AI capability to optimise and execute mapping, autonomous navigation, and disinfection routines based on proprietary algorithms.
The software also ensures the efficacy of SteraMist iHP disinfection under optimal operating parameters directed by TOMI.
TOMI's continuing research and development strategy will allow for the expansion of product lines to meet the urgent requirements of customers across a wide array of global industries. Advancements in programming will ensure protocol adherence during routine disinfection cycles at any time of day and allow programmed cycles to run during optimal times in an effort to reduce facility downtimes.
Further, the technology is expected to provide cost savings in manpower, providing a more efficient and effective disinfection building upon SteraMist's established no-touch, no rinse, no wipe, and no residue disinfection.
Dr Halden Shane, TOMI CEO, said: "SteraBot is an exciting breakthrough advancement for TOMI. SteraBot is one of many designs of TOMI disinfection robots. Stay tuned for additional robots' models being released in the very near future. We anticipate that SteraBot development to be our significant first step into robotics integration that will become an invaluable asset in protecting communities within the new normal, as well as propel TOMI's growth. The marketplace for an AI disinfection robot is maturing and TOMI should be able to take a significant share of it."